SURPASS-2 trial design: A phase 2, open-label study of ADP-A2M4CD8 SPEAR T cells in advanced esophageal or esophagogastric junction cancers Meeting Abstract
| Authors: | Hong, D. S.; Jalal, S. I.; Elimova, E.; Ajani, J. A.; Blum Murphy, M. A.; Cervantes, A.; Jeffry Evans, T. R.; Park, H.; Lin, Q.; Noto, P.; Shnaidman, M.; Campbell, D.; Rosenberg, M.; Brophy, F. E.; Danesi, H.; Ilson, D. H. |
| Abstract Title: | SURPASS-2 trial design: A phase 2, open-label study of ADP-A2M4CD8 SPEAR T cells in advanced esophageal or esophagogastric junction cancers |
| Meeting Title: | 2022 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2022 Jan 20-22 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-01 |
| Language: | English |
| ACCESSION: | WOS:000770995900352 |
| DOI: | 10.1200/JCO.2022.40.4_suppl.TPS363 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS363 -- Meeting was conducted online as well as in person -- Source: Wos |
